Feb 16, 2026 (MarketLine via COMTEX) --
Bioleaching unlocks revenue from low-grade ores, but the cost-effective copper extraction process is struggling to get off the ground.
The global bioleaching market was worth $10.14bn as of 2024 and is expected to grow to $21.37bn by 2033. The method is already used to produce up to 20% of the worldaEUR(TM)s copper and promises to offer cost-effective extraction, a new revenue stream and a rare environmental win for mining.
However, adoption is relatively slow, with varying time frames, high initial capital costs and a focus on low-grade ores largely pigeonholing the practice as a second-rate technology, sidelined in favour of high-grade ore smelting. With the exception of Latin America and China, bioleaching companies have generally struggled to reach commercial feasibility across markets.
Yet the metal picture is rapidly changing, and soaring demand for critical minerals and rare earth elements (REEs) means the appetite is there, albeit tentative. A pivot towards large-scale bioleaching is on the cards.
Plenty of major companies are investing in their own technologies, such as Rio TintoaEUR(TM)s Nuton venture. Driven by soaring demand, copper comprises the largest bioleaching market revenue share at more than 47.8%. Extraction involves the use of thermophilic, acidophilic bacteria such as aidithiobacillus ferrooxidans to metabolise sulphides in low-grade ores.
The biochemistry behind bioleaching for copperIn copper extraction, scientists employ chemolithoautotrophic microorganisms that use sulphur and iron as energy sources, or heterotrophic bacteria, which use organic compounds. At biomining company BiotaTec, operations also use archaea, bacteria and filamentous fungi.
In the case of chemolithoautotrophs, some microorganisms oxidise iron, some sulphur and some both. Those that oxidise iron generate energy by oxidising ferrous iron (Fe2+) into ferric iron (Fe3+), which reacts with copper ores, such as chalcocite or chalcopyrite, to release soluble copper ions. Meanwhile, those that oxidise sulphur produce sulphuric acid, maintaining the low pH required to keep the copper in the solution. Solid copper can then be extracted from the resultant pregnant leach solution, either through solvent extraction and electrowinning, or by cementation, which uses iron.
Heterotrophic bioleaching (using microorganisms that eat sugars) is used for non-sulphidic materials such as oxide ores (including malachite and chrysocolla), carbonate-rich ores and industrial waste. The bacteria metabolise carbon sources to produce organic acids, which react with copper oxide or carbonate ores to form soluble copper ions.
President and CEO of bioleaching company BacTech, Ross Orr, explains the process succinctly: aEURoeOur tagline is aEUR~our bugs eat rocksaEUR(TM).aEUR
In BacTechaEUR(TM)s case, the aEURoebugsaEUR in question are local. aEURoeYou tend to use the indigenous bacteria because they are there for a reason; they tend to be thermophiles or mesophiles. These are not patentable or anything,aEUR says Orr. aEURoeBioleaching is more a game of know-how, as opposed to trade secrets. It is nuance.aEUR
Nuance is achieved by matching the needs and economics of an operation with the bioleaching method. Heap and vat bioleaching are the two most commonly used methods, not only for copper but for all metals. However, the two offer opposing financial and logistics benefits and challenges.
Heap leaching is cheaper: crushed copper ore is piled up (aEUR~heapedaEUR(TM)) onto impermeable pads before bio-lixiviant is directly applied. The liquid copper percolates, and is collected and processed at low capital and operating costs. Comparatively simple logistically, heap leaching allows rapid startup and can be used for large volumes, usually of low-grade ore. However, copper recovery rates are low aEUR" usually between 70% and 90% aEUR" and the process takes months, or occasionally years, to complete.
In comparison, vat leaching involves fully submerging crushed copper ore in a bio-lixiviant, inside a vat. The solution percolates through the stationary ore bed, is collected and processed. Typically used for higher-grade ore, the technique offers a higher recovery rate and is a faster process, with processes spanning a period of days or weeks. While it avoids expenses associated with crushing ore, vat leaching is more expensive, as Orr notes: aEURoeWe use vat leaching, which deals with stainless tanks with impellers that are about a million bucks a pop.
aEURoeWe end up with this heavy soup of material that is agitated,aEUR he explains. aEURoeWe have big impellers that keep the concentrate suspended so the bacteria can get at it, because you don't want it all sitting on the bottom. We add some nutrients, depending on which strain we are using, and we get them to do in six days what would take them 20 years to do in nature. We speed up the process by giving them the Garden of Eden, and they work non-stop.aEUR
Commercial struggles in the global bioleaching marketThe copper question is inextricable from the larger bioleaching trend, meaning the sector is rife with both opportunities and commercialisation challenges. In short, bioleaching copper will become mainstream when bioleaching generally moves from viable to lucrative. It is happening, but slowly.
aEURoeBioleaching breaks up the matrix. The metals that are contained are really a function of the economics of pursuing them. You could have a little bit of copper in that soup, but it wouldn't be economically viable to produce a copper sulphate unless you had a percentage that was worth going after,aEURexplains Orr.
Around the world, some countries have been racing ahead with copper bioleaching commercialisation. As the world's largest copper producer, Chile is leading the way, and bioleaching is commonly used to extend mine life by making lower grade ore profitable. For example, at CodelcoaEUR(TM)s Radomiro Tomic mine in northern Chile, bioleaching plans were central to the decision to extend the siteaEUR(TM)s operational life from 2022 to 2030.
Elsewhere, however, there has been more industry sluggishness. In Europe, for example, there has been some interest in copper bioleaching from mining operators, but interest doesnaEUR(TM)t equate to profit.
aEURoeWe have worked with hundreds of mining companies all over the world already,aEUR says Darina AtyriakovAi, founder and CEO of Slovakian bioleaching company ekolive. aEURoeEverybody was interested in trialling it, but it was getting stuck at the corporate level. We did big pilots, presented it to the industry, but nobody was interested in financing it, so it never reached the industrial level.aEUR
Ekolive tried to target the copper market, and AtyriakovAi explains that the company developed technology to create sulphidic or oxidic forms of copper, noting: aEURoeWe even offered the technology to a very big copper processing plant, but somehow they were not interested in additional, local copper sources.aEUR
Instead, the company now focuses on the use of bioleaching for the remediation of soils and the production of ecological biostimulants, selling these as a product in the agricultural sector.
Orr echoes AtyriakovAiaEUR(TM)s sentiment around the struggles of commercialisation: aEURoeOur balance sheet is not strong. Our market cap is about C$10m [$7.34m]aEUR but it's a hell of a driver's seat to be in.aEUR
Where ekolive has forged a new path, pulling away from what should be a copper goldmine, BacTech is moving decisively into the downstream. The Canadian company has already built three bioleaching plants for operators including Allstate Exploration and Sino Gold Mining, and is now working on constructing its own in Ecuador, steering clear of the slow European market. Moving with the demand, and keeping all metals on the table, has been BacTechaEUR(TM)s most successful strategy so far.
aEURoeWe did a demonstration plant 20 years ago in Mexico with PeAoles on chalcopyrite [copper ore], but we have never used the technology, mostly because copper was very cheap,aEUR reflects Orr. aEURoeNext, we are looking at Peru, because Peru has enargite, which is a cousin of arsenopyrite. The difference, however, is that it includes copper, which is now a critical mineral, as well as gold and arsenic.aEUR
He adds that a bioleach plant dedicated specifically to copper is unlikely to ever be a core part of the vat-leaching companyaEUR(TM)s corporate strategy, because copper bioleaching requires vast quantities, which are best processed through bioheapleaching. However, he notes that the production of copper sulphate as a byproduct of gold and silver processing from enargite remains definitively on the cards.
Versatility boosts viabilityThere are several examples globally of copper-only bioleaching operations. Rio Tinto has been investing in Nuton for more than 30 years and announced first copper production from its Arizona Johnson Camp mine in December 2025. Elsewhere, the Zijinshan copper mine in China has been using large-scale bioheapleaching to process low-grade copper ores since 1998.
However, for bioleaching providers, copper might be an attractive market, but versatility is the name of the game.
In the case of BiotaTec, versatility has been the cornerstone of commercial success. aEURoeThe bioleaching sector is rapidly expanding to include all other types of materials. We are not talking about the low-grade ores anymore, but we are talking about industrial waste streams, phosphogypsum and bauxite residue,aEUR explains Priit JAuers, chief scientific officer at BiotaTec.
This versatility promises to be the key to the slippery European market. Although huge-scale industry operations and corporate bureaucracy can make adoption slow, Europe needs to strengthen its critical mineral supply chains, and it would be loath to turn down a readily accessible cache.
JAuers highlights phosphogypsum aEUR" a byproduct of phosphate fertiliser aEUR" which houses REEs including neodymium, praseodymium, dysprosium and terbium, often containing more than 60% of the REEs originally in the phosphate. Around four billion tonnes (bt) of phosphogypsum are stored around Europe.
BiotaTec already has several business cases in the rare earth space,Adeveloping bioleaching as a economically feasible option in contrast to technically doable but unrealistically expensive chemical leaching methods. However, JAuers explains that the company has its fingers in lots of pies: aEURoeThere are also end-of-life materials like wind turbine magnets and e-waste. People usually think of bioleaching as something that you apply for the low-grade stuff, but it is governed by the economic incentive.
aEURoeWe have successfully degraded end-of-life wind turbine magnets, which have 30% neodymium, which is higher than any of the ore that you can imagine. We can get over 80% of the neodymium-praseodymium out in three days, using only bacteria.aEUR
However, bioleaching isnaEUR(TM)t only a question of metal extraction; in some cases, it also offers a tailings management solution, offering the double whammy of decarbonisation and additional revenue streams.
This has been the case for BacTech, which has worked with Vale on nickel recovery from pyrrhotite, produced at its Sudbury site in Ontario, Canada. Pyrrhotite oxidises itself aggressively, and Vale has historically buried it under clay or in lakes, favouring the processing of high-grade pentlandite. It now has between 80 and 100 million tonnes of pyrrhotite tailings, which it approached BacTech with a view to processing via bioleaching.
aEURoeIt is predominantly iron, so we can make a magnetite, which we can direct ship to green steel. We add ammonia to the process after the bioleaching and it marries the sulphur to produce an organic fertiliser.
aEURoeWe found that only 25% of the value of one tonne of waste came from the nickel, copper and cobalt; 50% came from the fertiliser and the other 25% came from the iron. In the end, we are left with silica (sand), which can be used for paste backfill underground, or in geopolymers. It is truly a zero tailings process,aEUR explains Orr.
aEURoeWhy would you dig another hole in the ground for an iron ore mine when you have got 80bt of tailings sitting on surface globally?aEUR
For ekolive, commercial viability sits in biofertilisers, which it produces using a patented, EU-certified eco-bioleaching technology that uses bacteria to break down minerals, replicating natural soil-formation processes and creating a nutrient-rich, probiotic agricultural solution.
aEURoeWe are focusing on agriculture because we have commercial success there; it is easy and we have been in the space for a long time already,aEUR says AtyriakovAi. aEURoeWe will always cooperate with mining companies in bioleaching, but so far it is not reaching commercial application.aEUR
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
COMTEX_475311653/2227/2026-03-15T13:09:10
Copyright (C) 2026 Datamonitor. All rights reserved
